Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Safety and efficacy of combined Ipilimumab–Nivolumab in patients aged 80 years and older with advanced solid tumors (SITC 2026) - Oct 2, 2026 - Abstract #963; Pres time: Nov 6, 2026; 10:00 AM - 07:00 PM; Location: PCC - Lower Level - North Exhibition Halls 4-5-6; No abstract available 
Clinical • Metastases • Oncology • Solid Tumor
https://www.sitcancer.org/2026/abstracts/titles-and-publications?SITC%202026%20Abstracts%5BhitsPerPage%5D=100
 
Ayla Kouli; Haley M Meyer; Sherif Ahmed; Angelo Pirozzi; Christopher Dodoo; Ashish Chintakuntlawar; Shenduo Li; Yanyan Lou; Rami Manochakian; Vamsidhar Velcheti; Kaushal Parikh; Deepti Behl; Katherine Smith; Anastasios Dimou; Konstantinos Leventakos; Aaron Mansfield; Julian Molina; Vinicius Ernani; Antonious Hazim
 
Oct 2, 2026
 
Prev Next